Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET WAS VALUED AT USD 4,647.66 MILLION IN 2021 AND IS EXPECTED TO REACH USD 743.07 MILLION BY 2027, GROWING AT A CAGR OF (26.33%).
The Global COVID-19 Rapid Antigen Test Kits Market Size, Share, Trends, Analysis By
- Prescription: Professional and At-Home/OTC
- End-User: Hospitals & Clinics, Laboratories, Individuals/Homecare, and Others
- Geography: Europe, North America, APAC, Middle East & Africa, and Latin America
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast, 2022-2027
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
COVID-19 RAPID ANTIGEN TESTS KITS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| MARKET SIZE (2027) | USD 743 MILLION |
| CAGR | (26.33%) |
| BASE YEAR | 2021 |
| FORECAST YEAR | 2022-2027 |
| MARKET SEGMENTS | Prescription, End-User, and Geography |
| GEOGRAPHIC ANALYSIS | Europe, North America, APAC, Middle East & Africa, and Latin America |
| COUNTRIES COVERED | UK, France, Russia, Italy, Spain, Germany, Netherland, Poland, US, Canada, India, Australia, South Korea, Malaysia, China, Philippines, Japan, Turkey, Saudi Arabia, South Africa, Iran, Brazil, Mexico, Argentina, Peru, Columbia, and Chile |
MARKET INSIGHTS
The COVID-19 rapid antigen tests market is expected to reach $743.07 million by 2027. Antigen tests are commonly used in the diagnosis of pathogens, including influenza viruses and respiratory syncytial viruses. These tests are immunoassays that detect specific viral antigen and confirms the presence or absence of viral infection. Rapid antigen tests are currently authorized to be performed on nasal or nasopharyngeal swab specimens placed directly into the immunoassay’s extraction buffer or reagent. The currently available rapid antigen tests include point-of-care (POC) and laboratory-based tests, as well as self-tests performed at home, and they are commercially available to people of any age. A rapid antigen test is one of the widely used diagnostic tests to diagnose COVID-19 presence in an individual with or without symptoms. It offers a faster result and is relatively less expensive than PCR (polymerase chain reaction) or antibody tests.
The global COVID-19 rapid antigen tests market is a new and demanding market. The market is growing at a rapid pace due to the COVID-19 pandemic and will become a normal market like other infectious diseases.
The testing plays a significant role in containing and mitigating the pandemic by identifying the infected individual and stopping further person-to-person transmission. Rapid antigen testing is one of the primarily performed COVID-19 tests globally. This diagnosis determines the portion of virus protein and can give results within 15 minutes. Initially, PCR was considered the gold standard for COVID-19 diagnosis. However, over time, usage of rapid diagnostics kits has increased, and also, vendors have introduced highly sensitive COVID-19 rapid test kits.
Benefits of COVID-19 Rapid Antigen Testing
One of the significant advantages of people preferring rapid antigen testing devices is its quick results and more economic ability than other testing devices in the market. The demand for rapid COVID-19 antigen test kits is growing due to their low cost and easy use. The government in many countries is widely making the test kits available at a discounted price, which is one of the major factors boosting the adoption rate of home test kits.
Raise in Infection Spread
Multiple variants of the COVID-19 virus were identified across the globe. Governments started providing authorization for the emergency use of numerous test kits to increase access to COVID-19 tests. Countries such as the US and the UK started providing free home test kits, which has led to the high adoption of home test kits as these devices can be used without professional guidance.
Technological Advancements in COVID-19 Rapid Testing
Vendors designed various new rapid testing kits such as cups and cards and smart test kits, which were more sensitive and provided better results, almost equal to gold-standard PCR testing. There were painless rapid testing kits that used saliva samples. Test kits providing results in a shorter time were also introduced in the market. These advancements drive the usage of rapid testing over other COVID-19 testing kits. For instance, CoviFind COVID-19 Rapid Antigen Self-Test, a non-prescription product manufactured by Meril Diagnostics, an India-based, global medical company, has approval from ICMR for regular use in India self-test and is easily accessible.
Large academic institutes, and companies distributed home test kits at no cost to their stakeholders. This was a precautionary measure and peace of mind for the students and workers, helping people decide on the pandemic. Several steps are taken by the government, corporate companies, and academic institutes to increase the usage of COVID-19 rapid testing kits.
.
COVID-19 Rapid Antigen Testing Market
Mass Testing Strategy Among Countries & Robust Fundings for COVID-19 Testing
Robust testing strategies are seen as a significant aspect of preparedness and response to the COVID-19 pandemic, early detection of infection rates, and transmission, among others. Many countries started conducting COVID-19 mass testing strategies to reduce the spread of infections. People traveling from other countries were tested in airports, and migrating within-country required covid-19 certificates. Many were also tested on the spot using rapid test kits to reduce the spread of infections. Many NGOs, large regulatory bodies, and companies started manufacturing the COVID-19 test kits to tap the opportunity in the market. The increased investments made the companies increase their production volume. This, in turn, vastly increased the opportunities for COVID-19 rapid testing in the market.
One of the major limitations of rapid testing is the increased number of false-positive and negative results. There were cases with false-negative and false-positive reports in a set of COVID-19 test kits. People with COVID-19 symptoms were tested negative and tested positive when checked with alternative COVID-19 testing. These instances reduced the usage of COVID-19 rapid test kits in a few countries. Some countries like China still consider using RT-PCR tests for screening people.
Developed countries like the US, Germany, the UK, France, Italy, Canada, and Spain are conducting many COVID-19 rapid tests through OTC/Home tests and healthcare settings. People in developed countries purchase home testing kits and preserve them for future use. This is not the case in developing countries. Only symptomatic people prefer buying the kits to get tested. This trend differentiates the consumption pattern among the nations. A country like Canada has ordered more rapid test kits than its population count, whereas India has not.
GLOBAL COVID-19 RAPID ANTIGEN TESTING MARKET SHARE ANALYSIS
Europe dominated the COVID-19 rapid testing market by geography segment. However, APAC is expected to grow at a faster rate. Due to the increased adoption of rapid testing and quicker approval of COVID-19 rapid home test kits in Europe, the COVID-19 rapid antigen test kits market in Europe will remain dominant. North America was the second-largest market with faster product approvals, launches, and better distribution of home test kits. The United States launched new initiatives like testing with treatments, which means the treatment is provided as soon as the person is tested positive. These kinds of initiatives will primarily drive the usage of rapid test kits in the US. Hospitals & Clinics were the most significant users in the COVID-19 antigen test market. Mainly professional rapid testing was used in the hospitals & clinics segments. Individual segments had faster Covid-19 antigen test kits market growth rates. The demand for home test kits is increasing, and many companies are investing in manufacturing large volumes as there is a surge for home test kits in the market.
Professional test kits are in demand compared to other OTC/ Home test kits. After the complete vaccination process, the number of people suffering from COVID-19 infections will decrease. It will be like other viral infectious diseases. This will limit the people to get tested in healthcare settings like hospitals & clinics, compared to OTC/home conditions. This will significantly impact the OTC/home test kits, and they might become obsolete over time. Technological advancements like increased sensitivity and faster results are driving the usage of professional test kits in the industry. Since multiple strains of COVID-19 are encountered in the industry, impacting a large population, OTC/ Home test kits are expected to continue until many cases are reported.
Frequently Asked Questions
What was the size of the COVID-19 rapid antigen test kits market in 2021?
Who are the key players in the COVID-19 rapid antigen test kits market?
What are the growth opportunities in the Rapid Covid-19 antigen test kits market?
What are the strategies adopted by the players in the COVID-19 rapid antigen test kits market?
What are the growth enablers in the COVID-19 rapid antigen test kits market?
THE GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET IS EXPECTED TO REACH USD 743.07 MILLION BY 2027
The report considers the present scenario of the COVID-19 rapid antigen test kits market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
Base Year: 2021
Forecast Year: 2022-2027
Key Vendors
- Abbott
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- BD
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
- Bio-Rad Laboratories
Other Prominent Vendors
- AccuBioTech
- Business Overview
- Product Offerings
- AIVD Biotech
- AMEDA LABORDIAGNOSTIK
- ANP Technologies
- Angstrom Biotech
- ARISTA Biotech
- Assure Tech (Hangzhou)
- Biolidics
- BioMaxima SA
- Biopanda Reagents
- Biosynex
- BIOHIT Healthcare
- BioSpeedia
- BioMedomics
- BioTeke
- BTNX
- CTK Biotech
- CERTEST BIOTEC
- Celltrion
- Chembio Diagnostics
- Ellume
- Empowered Diagnostics
- FUJIFILM
- GUANGZHOU DECHENG BIOTECHNOLOGY
- Getein Biotech
- GenBody
- Hangzhou Alltest Biotech
- Hangzhou Clongene Biotech
- Healgen Scientific
- Wondfo
- KH Medical
- Lepu Medical Technology
- LumiraDx
- Mylab Discovery Solutions
- Meril Life Sciences
- Medicofarma
- nal von minden
- OraSure Technologies
- PerkinElmer
- Quidel
- Siemens Healthineers
- SD Biosensor
- Tianjin Era Biology Technology
- Xiamen Boson Biotech
- Zhejiang Orient Gene Biotech
Market Segmentation by Prescription
- Professional
- At-Home/OTC
Market Segmentation by End-User
- Hospitals & Clinics
- Laboratories
- Individuals/Homecare
- Others
Market Segmentation by Geography
- Europe
- UK
- France
- Russia
- Italy
- Spain
- Germany
- Netherland
- Poland
- North America
- US
- Canada
- APAC
- India
- Australia
- South Korea
- Malaysia
- China
- Philippines
- Japan
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- Iran
- Latin America
- Brazil
- Mexico
- Argentina
- Peru
- Columbia
- Chile
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 COVID-19 RAPID ANTIGEN TEST KITS SUPPLY CHAIN ANALYSIS
EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCES IN COVID-19 RAPID TEST KITS
EXHIBIT 5 IMPACT OF INCREASING MASS TESTING FOR COVID-19
EXHIBIT 6 IMPACT OF INTRODUCTION OF COVID-19 HOME TESTING KITS
EXHIBIT 7 IMPACT OF ROBUST FUNDING AND INVESTMENTS TO SCALE UP COVID-19 TEST KIT PRODUCTION
EXHIBIT 8 DISTRIBUTION OF COVID-19 RAPID ANTIGEN TESTS IN US (IN MILLION)
EXHIBIT 9 IMPACT OF INCREASED PRODUCT LAUNCHES
EXHIBIT 10 IMPACT OF INCREASING DONATIONS OF COVID-19 RAPID ANTIGEN TEST KITS
EXHIBIT 11 IMPACT OF RISING COVID-19 CASES
EXHIBIT 12 CONFIRMED COVID-19 CASES BY REGION (MILLION)
EXHIBIT 13 IMPACT OF INCREASED FALSE POSITIVE & FALSE NEGATIVE RESULTS
EXHIBIT 14 ALGORITHM FOR COVID-19 TEST INTERPRETATION USING RAPID ANTIGEN POINT-OF-CARE TEST
EXHIBIT 15 IMPACT OF INCREASING NON-REGULATED GENERIC TEST KITS
EXHIBIT 16 IMPACT OF DEFECTIVE GENERIC TEST KITS
EXHIBIT 17 COVID-19 WAVES & NEW VARIANT EVOLUTION
EXHIBIT 18 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 19 GLOBAL PRESCRIPTION COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021 & 2027 (%)
EXHIBIT 20 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER 2021 & 2027 (%)
EXHIBIT 21 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 22 FIVE FORCES ANALYSIS 2021
EXHIBIT 23 INCREMENTAL GROWTH BY PRESCRIPTION 2021 & 2027
EXHIBIT 24 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY PRESCRIPTION
EXHIBIT 25 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET BY PRESCRIPTION: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 26 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET BY PRESCRIPTION: ABSOLUTE GROWTH (%)
EXHIBIT 27 GLOBAL PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 28 GLOBAL PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 29 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 30 GLOBAL AT-HOME/OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL AT-HOME/OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 32 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 33 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 34 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER
EXHIBIT 35 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 36 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER: ABSOLUTE GROWTH (%)
EXHIBIT 37 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY HOSPITALS & CLINICS 2021–2027 ($ MILLION)
EXHIBIT 39 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET BY LABORATORIES 2021–2027 ($ MILLION)
EXHIBIT 41 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY INDIVIDUALS/HOMECARE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY INDIVIDUALS/HOME CARE 2021–2027 ($ MILLION)
EXHIBIT 43 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY OTHER END-USERS 2021–2027 ($ MILLION)
EXHIBIT 45 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 46 INCREMENTAL GROWTH BY PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS 2021 & 2027
EXHIBIT 47 OTC/AT-HOME COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL GROWTH 2021 & 2027
EXHIBIT 48 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
EXHIBIT 49 SHARE OF COUNTRIES IN MANUFACTURING COVID-19 RAPID ANTIGEN TESTS KITS
EXHIBIT 50 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 51 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 52 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 53 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 55 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 56 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN UK 2021–2027 ($ MILLION)
EXHIBIT 57 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 58 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN RUSSIA 2021–2027 ($ MILLION)
EXHIBIT 59 COVID-19 RAPID ANTIGEN TESTS MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 60 COVID-19 RAPID ANTIGEN TESTS MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 61 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 62 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN NETHERLANDS 2021–2027 ($ MILLION)
EXHIBIT 63 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN POLAND 2021–2027 ($ MILLION)
EXHIBIT 64 US COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
EXHIBIT 65 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 67 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 68 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN US 2021–2027 ($ MILLION)
EXHIBIT 69 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 70 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 71 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH ($ MILLION)
EXHIBIT 72 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 73 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 74 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 75 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN AUSTRALIA 2021–2027 ($ MILLION)
EXHIBIT 76 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 77 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN MALAYSIA 2021–2027 ($ MILLION)
EXHIBIT 78 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 79 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN PHILIPPINES 2021–2027 ($ MILLION)
EXHIBIT 80 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 81 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
EXHIBIT 82 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 83 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 84 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 85 COVID-19 RAPID ANTIGEN TESTS MARKET IN TURKEY 2021–2027 ($ MILLION)
EXHIBIT 86 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 87 SOUTH AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 88 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN IRAN 2021–2027 ($ MILLION)
EXHIBIT 89 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 90 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 91 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
EXHIBIT 92 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 93 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 94 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 95 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN ARGENTINA 2021–2027 ($ MILLION)
EXHIBIT 96 DISTRIBUTION OF COVID-19 TESTS TILL SEPTEMBER 2021
EXHIBIT 97 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN PERU 2021–2027 ($ MILLION)
EXHIBIT 98 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN COLOMBIA 2021–2027 ($ MILLION)
EXHIBIT 99 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN CHILE 2021–2027 ($ MILLION)
EXHIBIT 100 ABBOTT: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 101 ABBOTT: R&D EXPENDITURE 2018–2020 ($ MILLION)
EXHIBIT 102 ABBOTT REVENUE BY RAPID DIAGNOSTIC SEGMENTS 2018–2020 ($ MILLION)
EXHIBIT 103 BD: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 104 BD: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 105 BD: REVENUE BY INTEGRATED DIAGNOSTIC SOLUTIONS SEGMENT 2019-2021 ($ MILLION)
EXHIBIT 106 F.HOFFMANN-LA ROCHE: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 107 F.HOFFMANN-LA ROCHE: R&D EXPENDITURE 2018–2020 ($ MILLION)
EXHIBIT 108 F.HOFFMANN-LA ROCHE: REVENUE BY DIAGNOSTICS SEGMENT ($ MILLION)
EXHIBIT 109 F.HOFFMANN-LA ROCHE: MARKET SHARE BY GEOGRAPHY 2020 (DIAGNOSTICS SEGMENT)
EXHIBIT 110 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2018-2020 ($ MILLION)
EXHIBIT 111 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2018-2020 ($ MILLION)
EXHIBIT 112 THERMO FISHER SCIENTIFIC: REVENUE BY SPECIALTY DIAGNOSTICS SEGMENT ($ MILLION)
EXHIBIT 113 BIO-RAD LABORATORIES: TOTAL REVENUE 2018-2020 ($ MILLION)
EXHIBIT 114 BIO-RAD LABORATORIES: R&D EXPENDITURE 2018-2020 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 FIRST APPROVAL OF HOME-BASED COVID-19 RAPID TEST KITS
TABLE 4 LIST OF ICMR APPROVED COVID-19 HOME RAPID ANTIGEN TEST KITS
TABLE 5 VENDORS WITH NIH PROJECTS FOR DEVELOPING RAPID ANTIGEN TEST KITS
TABLE 6 COVID-19 RAPID ANTIGEN TEST KITS LAUNCHED DURING 2020-2022
TABLE 7 TOP 10 COUNTRIES WITH HIGH COVID-19 CASES (MILLION)
TABLE 8 COVID-19 RAPID ANTIGEN TESTS FOR PROFESSIONAL USE
TABLE 9 COVID-19 RAPID ANTIGEN TESTS FOR HOME/OTC USE
TABLE 10 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 11 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 12 EUROPE PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 13 EUROPE PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 14 EUROPE OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 15 EUROPE OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 16 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 17 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 18 NORTH AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 19 NORTH AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 20 NORTH AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 21 NORTH AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 22 GOVERNMENT AGREEMENTS WITH COVID-19 RAPID ANTIGEN TEST KIT SUPPLIERS
TABLE 23 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
TABLE 24 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 25 APAC PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 26 APAC PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027(%)
TABLE 27 APAC OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 28 APAC OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027(%)
TABLE 29 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 30 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 31 MIDDLE EAST & AFRICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 32 MIDDLE EAST & AFRICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 33 MIDDLE EAST & AFRICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 34 MIDDLE EAST & AFRICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 35 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 36 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 37 LATIN AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 38 LATIN AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 39 LATIN AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 40 LATIN AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021–2027 (%)
TABLE 41 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 42 BD: MAJOR PRODUCT OFFERINGS
TABLE 43 F.HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 44 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 45 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 46 ACCUBIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 47 AIVD BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 48 AMEDA LABORDIAGNOSTIK: MAJOR PRODUCT OFFERINGS
TABLE 49 ANP TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 50 ANGSTROM BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 51 ARISTA BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 52 ASSURE TECH (HANGZHOU): MAJOR PRODUCT OFFERINGS
TABLE 53 BIOLIDICS: MAJOR PRODUCT OFFERINGS
TABLE 54 BIOMAXIMA: MAJOR PRODUCT OFFERINGS
TABLE 55 BIOPANDA REAGENTS: MAJOR PRODUCT OFFERINGS
TABLE 56 BIOSYNEX: MAJOR PRODUCT OFFERINGS
TABLE 57 BIOHIT HEALTHCARE (HEFEI): MAJOR PRODUCT OFFERINGS
TABLE 58 BIOSPEEDIA: MAJOR PRODUCT OFFERINGS
TABLE 59 BIOMEDOMICS: MAJOR PRODUCT OFFERINGS
TABLE 60 BIOTEKE: MAJOR PRODUCT OFFERINGS
TABLE 61 BTNX: MAJOR PRODUCT OFFERINGS
TABLE 62 CTK BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 63 CERTEST BIOTEC: MAJOR PRODUCT OFFERINGS
TABLE 64 CELLTRION: MAJOR PRODUCT OFFERINGS
TABLE 65 CHEMBIO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 66 ELLUME: MAJOR PRODUCT OFFERINGS
TABLE 67 EMPOWERED DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 68 FUJIFILM: MAJOR PRODUCT OFFERINGS
TABLE 69 GUANGZHOU DECHENG BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 70 GETEIN BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 71 GENBODY: MAJOR PRODUCT OFFERINGS
TABLE 72 HANGZHOU ALLTEST BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 73 HANGZHOU CLONGENE BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 74 HEALGEN SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 75 KH MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 76 LEPU MEDICAL TECHNOLOGY (BEIJING): MAJOR PRODUCT OFFERINGS
TABLE 77 LUMIRADX: MAJOR PRODUCT OFFERINGS
TABLE 78 MYLAB DISCOVERY SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 79 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 80 MEDICOFARMA: MAJOR PRODUCT OFFERINGS
TABLE 81 NAL VON MINDEN: MAJOR PRODUCT OFFERINGS
TABLE 82 ORASURE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 83 PERKINELMER: MAJOR PRODUCT OFFERINGS
TABLE 84 QUIDEL: MAJOR PRODUCT OFFERINGS
TABLE 85 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 86 SD BIOSENSOR: MAJOR PRODUCT OFFERINGS
TABLE 87 TIANJIN ERA BIOLOGY TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 88 XIAMEN BOSON BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 89 WONDFO: MAJOR PRODUCT OFFERINGS
TABLE 90 ZHEJIANG ORIENT GENE BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 91 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 92 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 93 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY PRESCRIPTION 2021−2027 ($ MILLION)
TABLE 94 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY PRESCRIPTION 2021–2027 (%)
TABLE 95 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 96 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER 2021–2027 (%)
TABLE 97 NORTH AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 98 NORTH AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 99 NORTH AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 100 NORTH AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 101 NORTH AMERICA COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 102 NORTH AMERICA COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 103 EUROPE COVID-19 RAPID TEST KITS MARKET BY PROFESSIONAL 2021–2027 ($ MILLION)
TABLE 104 EUROPE PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 105 EUROPE OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 106 EUROPE OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 107 EUROPE COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 108 EUROPE COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 109 APAC PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 110 APAC PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 111 APAC OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 112 APAC OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 113 APAC COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 114 APAC COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 115 LATIN AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 116 LATIN AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 117 LATIN AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 118 LATIN AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 119 LATIN AMERICA COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 120 LATIN AMERICA COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 121 MIDDLE EAST& AFRICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 122 MIDDLE EAST & AFRICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 123 MIDDLE EAST & AFRICA OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 124 MIDDLE EAST & AFRICA OTC COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
TABLE 125 MIDDLE EAST& AFRICA COVID-19 RAPID TEST KITS MARKET 2021–2027 ($ MILLION)
TABLE 126 MIDDLE EAST &AFRICA COVID-19 RAPID TEST KITS MARKET 2021–2027 (%)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.4 MARKET SEGMENTS
4.4.1 MARKET SEGMENTATION BY PRESCRIPTION
4.4.2 MARKET SEGMENTATION BY END-USER
4.4.3 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT GLANCE
7 INTRODUCTION
7.1 BACKGROUND
7.1.1 OVERVIEW
7.1.2 INTRODUCTION
7.2 IMPACT OF COVID-19 ON GLOBAL SUPPLY CHAIN
7.2.1 IMPORTANCE OF COVID-19 TESTING
8 MARKET OPPORTUNITIES & TRENDS
8.1 TECHNOLOGICAL ADVANCES IN COVID-19 RAPID TEST KITS
8.2 INCREASING MASS TESTING FOR COVID-19
8.3 INTRODUCTION OF COVID-19 HOME TESTING KITS
9 MARKET GROWTH ENABLERS
9.1 ROBUST FUNDING & INVESTMENTS TO SCALE UP COVID-19 TEST KIT PRODUCTION
9.2 INCREASED PRODUCT LAUNCHES
9.3 INCREASING DONATIONS OF COVID-19 RAPID ANTIGEN TEST KITS
9.4 RISING COVID-19 CASES
10 MARKET GROWTH RESTRAINTS
10.1 INCREASED FALSE POSITIVE & FALSE NEGATIVE RESULTS
10.2 INCREASING NON-REGULATED GENERIC TEST KITS
10.3 DEFECTIVE GENERIC TEST KITS
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 INSIGHTS BY PRESCRIPTION
11.2.2 INSIGHTS BY END-USERS
11.2.3 INSIGHTS BY GEOGRAPHY
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRESCRIPTION
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 PROFESSIONAL
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
12.4 AT-HOME/OTC
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 AT-HOME/OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
13 END-USER
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 HOSPITALS & CLINICS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 LABORATORIES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.5 INDIVIDUALS/ HOMECARE
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.6 OTHERS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
14 GEOGRAPHY
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.1.1 PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
14.1.2 OTC/AT-HOME COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
14.2 GEOGRAPHIC OVERVIEW
15 EUROPE
15.1 MARKET OVERVIEW
15.2 MARKET SIZE & FORECAST
15.3 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET
15.4 EUROPE PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
15.5 EUROPE OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
15.6 KEY COUNTRIES
15.6.1 UK: MARKET SIZE & FORECAST
15.6.2 FRANCE: MARKET SIZE & FORECAST
15.6.3 RUSSIA: MARKET SIZE & FORECAST
15.6.4 ITALY: MARKET SIZE & FORECAST
15.6.5 SPAIN: MARKET SIZE & FORECAST
15.6.6 GERMANY: MARKET SIZE & FORECAST
15.6.7 NETHERLANDS: MARKET SIZE & FORECAST
15.6.8 POLAND: MARKET SIZE & FORECAST
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET
16.4 NORTH AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KIT MARKET
16.5 NORTH AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
16.6 KEY COUNTRIES
16.6.1 US: MARKET SIZE & FORECAST
16.6.2 CANADA: MARKET SIZE & FORECAST
17 APAC
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET
17.4 APAC PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
17.5 APAC OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
17.6 KEY COUNTRIES
17.6.1 INDIA: MARKET SIZE & FORECAST
17.6.2 AUSTRALIA: MARKET SIZE & FORECAST
17.6.3 SOUTH KOREA: MARKET SIZE & FORECAST
17.6.4 MALAYSIA: MARKET SIZE & FORECAST
17.6.5 CHINA: MARKET SIZE & FORECAST
17.6.6 PHILIPPINES: MARKET SIZE & FORECAST
17.6.7 JAPAN: MARKET SIZE & FORECAST
18 MIDDLE EAST & AFRICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 MIDDLE EAST &AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET
18.4 MIDDLE EAST &AFRICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
18.5 MIDDLE EAST &AFRICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
18.6 KEY COUNTRIES
18.6.1 TURKEY: MARKET SIZE & FORECAST
18.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
18.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
18.6.4 IRAN: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET
19.4 LATIN AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
19.5 LATIN AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
19.6 KEY COUNTRIES
19.6.1 BRAZIL: MARKET SIZE & FORECAST
19.6.2 MEXICO: MARKET SIZE & FORECAST
19.6.3 ARGENTINA: MARKET SIZE & FORECAST
19.6.4 PERU: MARKET SIZE & FORECAST
19.6.5 COLOMBIA: MARKET SIZE & FORECAST
19.6.6 CHILE: MARKET SIZE & FORECAST
20 COMPETITIVE LANDSCAPE
20.1 COMPETITION OVERVIEW
20.2 MARKET SHARE ANALYSIS
20.2.1 ABBOTT
20.2.2 BD
20.2.3 F.HOFFMANN-LA ROCHE
20.2.4 THERMO FISHER SCIENTIFIC
20.2.5 BIO-RAD LABORATORIES
21 KEY COMPANY PROFILES
21.1 ABBOTT
21.1.1 BUSINESS OVERVIEW
21.1.2 PRODUCT OFFERINGS
21.1.3 KEY STRATEGIES
21.1.4 KEY STRENGTHS
21.1.5 KEY OPPORTUNITIES
21.2 BD
21.2.1 BUSINESS OVERVIEW
21.2.2 PRODUCT OFFERINGS
21.2.3 KEY STRATEGIES
21.2.4 KEY STRENGTHS
21.2.5 KEY OPPORTUNITIES
21.3 F.HOFFMANN-LA ROCHE
21.3.1 BUSINESS OVERVIEW
21.3.2 PRODUCT OFFERINGS
21.3.3 KEY STRATEGIES
21.3.4 KEY STRENGTHS
21.3.5 KEY OPPORTUNITIES
21.4 THERMO FISHER SCIENTIFIC
21.4.1 BUSINESS OVERVIEW
21.4.2 PRODUCT OFFERINGS
21.4.3 KEY STRATEGIES
21.4.4 KEY STRENGTHS
21.4.5 KEY OPPORTUNITIES
21.5 BIO-RAD LABORATORIES
21.5.1 BUSINESS OVERVIEW
21.5.2 PRODUCT OFFERINGS
21.5.3 KEY STRATEGIES
21.5.4 KEY STRENGTHS
21.5.5 KEY OPPORTUNITIES
22 OTHER PROMINENT VENDORS
22.1 ACCUBIOTECH
22.1.1 BUSINESS OVERVIEW
22.1.2 PRODUCT OFFERINGS
22.2 AIVD BIOTECH
22.2.1 BUSINESS OVERVIEW
22.2.2 PRODUCT OFFERINGS
22.3 AMEDA LABORDIAGNOSTIK
22.3.1 BUSINESS OVERVIEW
22.3.2 PRODUCT OFFERINGS
22.4 ANP TECHNOLOGIES
22.4.1 BUSINESS OVERVIEW
22.4.2 PRODUCT OFFERINGS
22.5 ANGSTROM BIOTECH
22.5.1 BUSINESS OVERVIEW
22.5.2 PRODUCT OFFERINGS
22.6 ARISTA BIOTECH
22.6.1 BUSINESS OVERVIEW
22.6.2 PRODUCT OFFERINGS
22.7 ASSURE TECH (HANGZHOU)
22.7.1 BUSINESS OVERVIEW
22.7.2 PRODUCT OFFERINGS
22.8 BIOLIDICS
22.8.1 BUSINESS OVERVIEW
22.8.2 PRODUCT OFFERINGS
22.9 BIOMAXIMA
22.9.1 BUSINESS OVERVIEW
22.9.2 PRODUCT OFFERINGS
22.10 BIOPANDA REAGENTS
22.10.1 BUSINESS OVERVIEW
22.10.2 PRODUCT OFFERINGS
22.11 BIOSYNEX
22.11.1 BUSINESS OVERVIEW
22.11.2 PRODUCT OFFERINGS
22.12 BIOHIT HEALTHCARE (HEFEI)
22.12.1 BUSINESS OVERVIEW
22.12.2 PRODUCT OFFERINGS
22.13 BIOSPEEDIA
22.13.1 BUSINESS OVERVIEW
22.13.2 PRODUCT OFFERINGS
22.14 BIOMEDOMICS
22.14.1 BUSINESS OVERVIEW
22.14.2 PRODUCT OFFERINGS
22.15 BIOTEKE (WUXI)
22.15.1 BUSINESS OVERVIEW
22.15.2 PRODUCT OFFERINGS
22.16 BTNX
22.16.1 BUSINESS OVERVIEW
22.16.2 PRODUCT OFFERINGS
22.17 CTK BIOTECH
22.17.1 BUSINESS OVERVIEW
22.17.2 PRODUCT OFFERINGS
22.18 CERTEST BIOTEC
22.18.1 BUSINESS OVERVIEW
22.18.2 PRODUCT OFFERINGS
22.19 CELLTRION
22.19.1 BUSINESS OVERVIEW
22.19.2 PRODUCT OFFERINGS
22.20 CHEMBIO DIAGNOSTICS
22.20.1 BUSINESS OVERVIEW
22.20.2 PRODUCT OFFERINGS
22.21 ELLUME
22.21.1 BUSINESS OVERVIEW
22.21.2 PRODUCT OFFERINGS
22.22 EMPOWERED DIAGNOSTICS
22.22.1 BUSINESS OVERVIEW
22.22.2 PRODUCT OFFERINGS
22.23 FUJIFILM
22.23.1 BUSINESS OVERVIEW
22.23.2 PRODUCT OFFERINGS
22.24 GUANGZHOU DECHENG BIOTECHNOLOGY
22.24.1 BUSINESS OVERVIEW
22.24.2 PRODUCT OFFERINGS
22.25 GETEIN BIOTECH
22.25.1 BUSINESS OVERVIEW
22.25.2 PRODUCT OFFERINGS
22.26 GENBODY
22.26.1 BUSINESS OVERVIEW
22.26.2 PRODUCT OFFERINGS
22.27 HANGZHOU ALLTEST BIOTECH
22.27.1 BUSINESS OVERVIEW
22.27.2 PRODUCT OFFERINGS
22.28 HANGZHOU CLONGENE BIOTECH
22.28.1 BUSINESS OVERVIEW
22.28.2 PRODUCT OFFERINGS
22.29 HEALGEN SCIENTIFIC
22.29.1 BUSINESS OVERVIEW
22.29.2 PRODUCT OFFERINGS
22.30 KH MEDICAL
22.30.1 BUSINESS OVERVIEW
22.30.2 PRODUCT OFFERINGS
22.31 LEPU MEDICAL TECHNOLOGY (BEIJING)
22.31.1 BUSINESS OVERVIEW
22.31.2 PRODUCT OFFERINGS
22.32 LUMIRADX
22.32.1 BUSINESS OVERVIEW
22.32.2 PRODUCT OFFERINGS
22.33 MYLAB DISCOVERY SOLUTIONS
22.33.1 BUSINESS OVERVIEW
22.33.2 PRODUCT OFFERINGS
22.34 MERIL LIFE SCIENCES
22.34.1 BUSINESS OVERVIEW
22.34.2 PRODUCT OFFERINGS
22.35 MEDICOFARMA
22.35.1 BUSINESS OVERVIEW
22.35.2 PRODUCT OFFERINGS
22.36 NAL VON MINDEN
22.36.1 BUSINESS OVERVIEW
22.36.2 PRODUCT OFFERINGS
22.37 ORASURE TECHNOLOGIES
22.37.1 BUSINESS OVERVIEW
22.37.2 PRODUCT OFFERINGS
22.38 PERKINELMER
22.38.1 BUSINESS OVERVIEW
22.38.2 PRODUCT OFFERINGS
22.39 QUIDEL
22.39.1 BUSINESS OVERVIEW
22.39.2 PRODUCT OFFERINGS
22.40 SIEMENS HEALTHINEERS
22.40.1 BUSINESS OVERVIEW
22.40.2 PRODUCT OFFERINGS
22.41 SD BIOSENSOR
22.41.1 BUSINESS OVERVIEW
22.41.2 PRODUCT OFFERINGS
22.42 TIANJIN ERA BIOLOGY TECHNOLOGY
22.42.1 BUSINESS OVERVIEW
22.42.2 PRODUCT OFFERINGS
22.43 XIAMEN BOSON BIOTECH
22.43.1 BUSINESS OVERVIEW
22.43.2 PRODUCT OFFERINGS
22.44 WONDFO
22.44.1 BUSINESS OVERVIEW
22.44.2 PRODUCT OFFERINGS
22.45 ZHEJIANG ORIENT GENE BIOTECH
22.45.1 BUSINESS OVERVIEW
22.45.2 PRODUCT OFFERINGS
23 REPORT SUMMARY
23.1 KEY TAKEAWAYS
23.2 STRATEGIC RECOMMENDATIONS
24 QUANTITATIVE SUMMARY
24.1 MARKET BY GEOGRAPHY
24.2 MARKET BY PRESCRIPTION
24.3 MARKET BY END-USER
24.4 NORTH AMERICA: PROFESSIONAL
24.5 NORTH AMERICA: OTC
24.6 NORTH AMERICA: COVID-19 RAPID ANTIGEN TEST KITS MARKET
24.7 EUROPE: PROFESSIONAL
24.8 EUROPE: OTC
24.9 EUROPE: COVID-19 RAPID ANTIGEN TEST KITS MARKET
24.10 APAC: PROFESSIONAL
24.11 APAC: OTC
24.12 APAC: COVID-19 RAPID ANTIGEN TEST KITS MARKET
24.13 LATIN AMERICA: PROFESSIONAL
24.14 LATIN AMERICA: OTC
24.15 LATIN AMERICA: COVID-19 RAPID ANTIGEN TEST KITS MARKET
24.16 MIDDLE EAST& AFRICA: PROFESSIONAL
24.17 MIDDLE EAST& AFRICA: OTC
24.18 MIDDLE EAST& AFRICA: COVID-19 RAPID ANTIGEN TEST KITS MARKET
25 APPENDIX
25.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What was the size of the COVID-19 rapid antigen test kits market in 2021?
Who are the key players in the COVID-19 rapid antigen test kits market?
What are the growth opportunities in the Rapid Covid-19 antigen test kits market?
What are the strategies adopted by the players in the COVID-19 rapid antigen test kits market?
What are the growth enablers in the COVID-19 rapid antigen test kits market?
other RELATED Reports
COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026
Published : December 2020
Hematology Diagnostics Market - Global Outlook & Forecast 2022-2027
Published : December 2021